Search Results - "Szydło, Anna"

Anticancer effects of CAMEL peptide by Smolarczyk, Ryszard, Cichoń, Tomasz, Kamysz, Wojciech, Głowala-Kosińska, Magdalena, Szydło, Anna, Szultka, Łukasz, Sieroń, Aleksander L, Szala, Stanisław

“…This study analyzed whether therapy with CAMEL, an antimicrobial peptide (KWKLFKKIGAVLKVL), possess anticancer benefits. Although the peptide was cytotoxic for…”
Get full text

Mutations in mammalian tolloid-like 1 gene detected in adult patients with ASD by STANCZAK, Pawet, WITECKA, Joanna, SZYDLO, Anna, GUTMAJSTER, Ewa, LISIK, Malgorzata, AUGUSCIAK-DUMA, Aleksandra, TARNOWSKI, Maciej, CZEKAJ, Tomasz, CZEKAJ, Hanna, SIERON, Aleksander L

“…Atrial septal defect (ASD) is an incomplete septation of atria in human heart causing circulatory problems. Its frequency is estimated at one per 10 000…”
Get full text

Optimization of genetic engineering and homologous recombination of collagen type I genes in rat bone marrow mesenchymal stem cells (MSC) by Tarnowski, Maciej, Szydło, Anna, Anioł, Jacek, Koryciak-Komarska, Halina, Lesiak, Marta, Gutmajster, Ewa, Sieroń, Aleksander L, Kusz, Damian

“…Mutations in COL1A1 or COL1A2 genes lead to osteogenesis Imperfecta (OI) in humans. There are three possiblities to successfully treat OI including (1) gene…”
Get more information

Blocking angiogenesis with peptides that inhibit the activity of procollagen C-endopeptidase by Lesiak, Marta, Auguściak-Duma, Aleksandra, Szydło, Anna, Sieroń, Aleksander L.

“…Procollagen C-endopeptidase (BMP-1) is one of two key enzymes crucial for conversion of fibrillar procollagens to self-assembling collagen monomers…”
Get full text

Two novel COL1A1 mutations in patients with osteogenesis imperfecta (OI) affect the stability of the collagen type I triple-helix by Witecka, Joanna, Auguściak-Duma, Aleksandra M, Kruczek, Anna, Szydło, Anna, Lesiak, Marta, Krzak, Maria, Pietrzyk, Jacek J, Männikkö, Minna, Sieroń, Aleksander L

“…Osteogenesis imperfecta (OI) is a bone dysplasia caused by mutations in the COL1A1 and COL1A2 genes. Although the condition has been intensely studied for over…”
Get full text

Two novelCOL1A1 mutations in patients with osteogenesis imperfecta (OI) affect the stability of the collagen type I triple-helix by Witecka, Joanna, Auguściak-Duma, Aleksandra M., Kruczek, Anna, Szydło, Anna, Lesiak, Marta, Krzak, Maria, Pietrzyk, Jacek J., Männikkö, Minna, Sieroń, Aleksander L.

“…Osteogenesis imperfecta (OI) is a bone dysplasia caused by mutations in the COL1A1 and COL1A2 genes. Although the condition has been intensely studied for over…”
Get full text

The challenges of hypervolemic therapy in patients after subarachnoid haemorrhage by Szmuda, Tomasz, Waszak, Przemyslaw M, Rydz, Cezary, Springer, Janusz, Budynko, Lukasz, Szydlo, Anna, Sloniewski, Pawel, Dzierżanowski, Jarosław

“…The triple-H therapy is widely used for cerebral vasospasm (CV) prevention and treatment in patients after subarachnoid haemorrhage (SAH). However, this…”
Get more information

Specific inhibition of procollagen C-endopeptidase activity by synthetic peptide with conservative sequence found in chordin by Lesiak, Marta, Augusciak-Duma, Aleksandra, Szydlo, Anna, Pruszczynska, Ksymena, Sieron, Aleksander L

“…Procollagen C-endopeptidase (BMP-1) and N-endopeptidase (ADAMTS-2) are key enzymes for correct and efficient conversion of fibrillar procollagens to their self…”
Get full text